- Home
- AYTU vs KAVL Comparison
AYTU vs KAVL Comparison
Compare AYTU & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- KAVL
- Stock Information
- Founded
- AYTU N/A
- KAVL 1998
- Country
- AYTU United States
- KAVL United States
- Employees
- AYTU N/A
- KAVL N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- KAVL Medicinal Chemicals and Botanical Products
- Sector
- AYTU Health Care
- KAVL Health Care
- Exchange
- AYTU Nasdaq
- KAVL Nasdaq
- Market Cap
- AYTU 9.6M
- KAVL 7.9M
- IPO Year
- AYTU N/A
- KAVL N/A
- Fundamental
- Price
- AYTU $2.10
- KAVL $0.49
- Analyst Decision
- AYTU
- KAVL
- Analyst Count
- AYTU 0
- KAVL 0
- Target Price
- AYTU N/A
- KAVL N/A
- AVG Volume (30 Days)
- AYTU 624.8K
- KAVL 28.5K
- Earning Date
- AYTU 05-14-2025
- KAVL 06-10-2025
- Dividend Yield
- AYTU N/A
- KAVL N/A
- EPS Growth
- AYTU N/A
- KAVL N/A
- EPS
- AYTU N/A
- KAVL N/A
- Revenue
- AYTU $81,659,000.00
- KAVL $1,698,426.00
- Revenue This Year
- AYTU N/A
- KAVL N/A
- Revenue Next Year
- AYTU $8.68
- KAVL N/A
- P/E Ratio
- AYTU $11.39
- KAVL N/A
- Revenue Growth
- AYTU 0.41
- KAVL N/A
- 52 Week Low
- AYTU $0.95
- KAVL $0.46
- 52 Week High
- AYTU $2.96
- KAVL $1.95
- Technical
- Relative Strength Index (RSI)
- AYTU 60.77
- KAVL 36.05
- Support Level
- AYTU $1.97
- KAVL $0.52
- Resistance Level
- AYTU $2.17
- KAVL $0.56
- Average True Range (ATR)
- AYTU 0.14
- KAVL 0.03
- MACD
- AYTU 0.00
- KAVL -0.00
- Stochastic Oscillator
- AYTU 58.33
- KAVL 0.57
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.